Lumi Lash: Unlicensed product with ingredient on prescription drug list.
Last updated
Summary
Product
Lumi Lash
Issue
Health products - Unauthorized product
Health products - Undeclared substance
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lots |
|---|---|---|---|---|---|
Lumi Lash |
Lumi Lash |
No market authorization |
Liquid |
N/A |
20220331, 20201220 |
Issue
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date: 2022-08-25
Alert / recall type
Health product recall
Category
Health product - Drugs
Companies
Lumi Beauty
17008 90 Ave, #431, Edmonton
AB, T5T 1L6
Published by
Health Canada
Audience
General public
Healthcare
Industry
Retail
Recall class
Type II
Identification number
RA-64507